
|Videos|May 15, 2017
HIPEC for Colorectal Cancer With Peritoneal Carcinomatosis
Author(s)Hans Schlitt, MD
This video reviews the use of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery in colorectal cancer with peritoneal carcinomatosis.
Advertisement
Peritoneal carcinomatosis, present in about 10% to 15% of colorectal patients at the time of diagnosis, is difficult to detect by imaging and often only discovered intraoperatively.
In this video, Hans Schlitt, MD, of the University of Regensburg Medical Center in Germany, discusses the use of hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery in this setting, which in selected patients is associated with improved survival.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Combatting Toxicities and Leveraging Novel Therapies in Lung Cancer Care
2
Acalabrutinib Approval Offers Time-Limited Approach in CLL/SLL
3
Elucidating Treatment Selection for Metastatic HSPC at ASCO GU 2026
4
Supervised Keto Diet/Triplet Chemo Improves Survival in Pancreatic Cancer
5



























































